Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K T Muir

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Anesthesiology|April 1, 1996
Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver diseaseM Dershwitz, J F Hoke, C E Rosow, et al.
Anesthesiology|September 22, 1998
Remifentanil pharmacokinetics in obese versus lean patientsT D Egan, B Huizinga, S K Gupta, et al.
Anesthesiology|November 1, 1993
The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteersT D Egan, H J Lemmens, P Fiset, et al.
Anesthesiology|November 1, 1995
Measured context-sensitive half-times of remifentanil and alfentanilA Kapila, P S Glass, J R Jacobs, et al.
Anesthesia and Analgesia|April 1, 1997
Remifentanil and pulmonary extraction during and after cardiac anesthesiaD J Duthie, J J Stevens, A R Doyle, et al.
Journal of Cardiovascular Pharmacology|October 1, 1990
Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patientsS H Jackson, A M Shepherd, T M Ludden, et al.
Anesthesia and Analgesia|December 1, 2001
Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic proceduresA K Ross, P J Davis, G L Dear Gd, et al.
Anesthesiology|October 8, 1997
Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteersJ F Hoke, D Shlugman, M Dershwitz, et al.
Anesthesiology|January 1, 1997
Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model developmentC F Minto, T W Schnider, T D Egan, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Anesthesiology|April 1, 1996
Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver diseaseM Dershwitz, J F Hoke, C E Rosow, et al.
Anesthesiology|September 22, 1998
Remifentanil pharmacokinetics in obese versus lean patientsT D Egan, B Huizinga, S K Gupta, et al.
Anesthesiology|November 1, 1993
The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteersT D Egan, H J Lemmens, P Fiset, et al.
Anesthesiology|November 1, 1995
Measured context-sensitive half-times of remifentanil and alfentanilA Kapila, P S Glass, J R Jacobs, et al.
Anesthesia and Analgesia|April 1, 1997
Remifentanil and pulmonary extraction during and after cardiac anesthesiaD J Duthie, J J Stevens, A R Doyle, et al.
Journal of Cardiovascular Pharmacology|October 1, 1990
Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patientsS H Jackson, A M Shepherd, T M Ludden, et al.
Anesthesia and Analgesia|December 1, 2001
Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic proceduresA K Ross, P J Davis, G L Dear Gd, et al.
Anesthesiology|October 8, 1997
Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteersJ F Hoke, D Shlugman, M Dershwitz, et al.
Anesthesiology|January 1, 1997
Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model developmentC F Minto, T W Schnider, T D Egan, et al.
Pageof 4